38
Companies
80+
Technologies
100+
Literature Reviews
75+
Educational Materials
20+
Statistical Analyses
80+
Value Materials
40+
Abstracts, Posters & Oral Presentations
20+
Whitepapers
80+
Manuscripts
20+
Economic Models
15+
Advisory Boards & Symposia
50+
Creative Collaborations
We specialise in generating solutions to address the additional challenges manufacturers must overcome for successful market access and reimbursement of new and existing medical technologies.
Our team also has extensive experience of keeping pace with technological advancements in MedTech, including technologies with unique barriers to market access. We have experience of digital technologies wherein the ultimate benefit to patients, HCPs and payers cannot be directly demonstrated via “traditional” clinical or economic endpoints, requiring innovative approaches to evidence generation, coupled with bespoke, compelling value messaging to gain market entry.
Our team works across pharmaceutical and MedTech projects, allowing us to apply clinical and health economic expertise and knowledge of our state-of the-art service offerings to the challenges unique to MedTech.
Our Consultants work with you from project conception to completion, investing considerable time tailoring to your needs and ensuring competitive pricing, and giving you a dedicated, highly experienced point of contact invested in successful project delivery. Our knowledgeable, flexible team can provide support and advice at every stage of your product’s life cycle.
The MedTech industry continues to evolve, but remains a complex environment for manufacturers to achieve market access for technologies. As the healthcare industry looks to MedTech to address the critical challenges facing systems worldwide, we have recently reflected on recent announcements within the UK whilst considering the broader role for Medical Affairs:
